It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Antiplatelet combinations for prevention of atherothrombotic events
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

14844

Antiplatelet combinations for prevention of atherothrombotic events



Review

(7373) Total Article Views


Authors: Mario Bollati, Fiorenzo Gaita, Matteo Anselmino

Published Date January 2011 Volume 2011:7 Pages 23 - 30
DOI: http://dx.doi.org/10.2147/VHRM.S12271

Mario Bollat,i Fiorenzo Gaita, Matteo Anselmino
Department of Internal Medicine, Division of Cardiology, University of Torino, Italy

Abstract: Antiplatelet therapy plays a fundamental role in reducing atherothrombotic events by several pathways. The present work reviews available evidence on antiplatelet therapy both for primary prevention and in the presence of established peripheral, cerebral, or cardiac ischemic disease. Due to the importance of adherence to therapy to achieve optimal effects, special attention is given to the use of fixed-dose oral formulations in the clinical subset of patients in whom double antiplatelet therapy has proven indications.

Keywords: aspirin, clopidogrel, ticlopidine, fixed-dose combinations

 




Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter


Readers of this article also read:

  • ACC 2014

    We will attend the 2014 American College of Cardiology Scientific Session and Expo (ACC) on March 29-31, 2014. Stop by booth 3217 to talk with us.

  • Like us on Facebook

    Click the blue link above to become a part of our Facebook community.